Table 2 Results of a univariate analysis to identify predictors for each complication
Positive | Negative | p-value | |
|---|---|---|---|
a. Overall morbidity | |||
209 (51.7%) | 195 (48.3%) | ||
DOV on POD1 (ml) | 280 (15–1490) | 258 (50–1475) | 0.556 |
DA on POD1 (U/l) | 1433 (0–95,100) | 429 (9–15,280) | < 0.0001 |
WBC counts on POD1 (/μl) | 10,640 (820–113,800) | 10,330 (635–28,350) | 0.383 |
CRP on POD1 (mg/dl) | 10.330 (0.79–25.84) | 8.970 (0.09–17.50) | < 0.001 |
DOV on POD3 (ml) | 256 (0–1061) | 210 (0–1573) | 0.085 |
DA on POD3 (U/l) | 163 (3–17,200) | 67 (6–11,863) | < 0.0001 |
WBC counts on POD3 (/μl) | 9060 (730–23,710) | 8325 (2260–26,230) | 0.012 |
CRP on POD3 (mg/dl) | 14.330 (0.87–42.32) | 10.470 (0.98–37.57) | < 0.0001 |
b. Major complications | |||
100 (24.8%) | 304 (75.2%) | ||
DOV on POD1 (ml) | 274.5 (15–1490) | 235 (50–1350) | 0.165 |
DA on POD1 (U/l) | 1836 (0–95,100) | 458 (6–54,600) | < 0.0001 |
WBC counts on POD1 (/μl) | 10,380 (1140–113,800) | 10,400 (635–28,350) | 0.909 |
CRP on POD1 (mg/dl) | 10.680 (1.42–25.84) | 9.130 (0.09–18.40) | < 0.001 |
DOV on POD3 (ml) | 174 (0–1210) | 250 (0–1573) | 0.008 |
DA on POD3 (U/l) | 213.5 (3–14,272) | 72 (5–17,200) | < 0.0001 |
WBC counts on POD3 (/μl) | 10,275 (1460–21,570) | 8300 (730–26,230) | < 0.001 |
CRP on POD3 (mg/dl) | 18.890 (3.76–42.32) | 10.810 (0.87–37.57) | < 0.0001 |
c. IAI | |||
135 (33.4%) | 269 (66.7%) | ||
DOV on POD1 (ml) | 240 (50–1475) | 286 (15–1490) | 0.009 |
DA on POD1 (U/l) | 1836 (0–95,100) | 338 (6–54,600) | < 0.0001 |
WBC counts on POD1 (/μl) | 10,840 (1140–113,800) | 10,050 (635–28,350) | 0.059 |
CRP on POD1 (mg/dl) | 10.440 (0.79–25.84) | 9.000 (0.09–17.50) | < 0.001 |
DOV on POD3 (ml) | 328 (0–1210) | 410 (0–1573) | < 0.001 |
DA on POD3 (U/l) | 224 (3–17,200) | 67 (5–11,863) | < 0.0001 |
WBC counts on POD3 (/μl) | 10,180 (730–23,710) | 8275 (2260–26,230) | < 0.0001 |
CRP on POD3 (mg/dl) | 16.350 (3.65–42.32) | 10.430 (0.87–37.57) | < 0.0001 |
d. CR-POPF | |||
75 (18.6%) | 329 (81.4%) | ||
DOV on POD1 (ml) | 178 (50–730) | 290 (15–1490) | < 0.0001 |
DA on POD1 (U/l) | 4374 (4–95,100) | 458.5 (0–54,600) | < 0.0001 |
WBC counts on POD1 (/μl) | 10,640 (1140–113,800) | 10,330 (635–28,350) | 0.383 |
CRP on POD1 (mg/dl) | 10.490 (1.26–19.62) | 9.280 (0.09–25.84) | 0.007 |
DOV on POD3 (ml) | 178 (0–1573) | 250 (0–1061) | 0.029 |
DA on POD3 (U/l) | 453.5 (3–17,200) | 72 (5–11,863) | < 0.0001 |
WBC counts on POD3 (/μl) | 10,420 (1460–21,570) | 8510 (730–26,230) | 0.005 |
CRP on POD3 (mg/dl) | 18.625 (2.57–42.32) | 11.260 (0.87–37.57) | < 0.0001 |
e. CR-DGE | |||
23 (5.7%) | 381 (94.3%) | ||
DOV on POD1 (ml) | 266 (15–1490) | 266 (82–1300) | 0.546 |
DA on POD1 (U/l) | 213 (6–16,420) | 735 (0–95,100) | 0.092 |
WBC counts on POD1 (/μl) | 10,400 (635–113,800) | 9390 (5300–17,460) | 0.28 |
CRP on POD1 (mg/dl) | 9.245 (5.01–15.58) | 9.495 (0.09–25.84) | 0.7 |
DOV on POD3 (ml) | 236 (0–1573) | 212 (35–830) | 0.693 |
DA on POD3 (U/l) | 46 (9–1289) | 104 (3–17,200) | 0.237 |
WBC counts on POD3 (/μl) | 7710 (2630–13,220) | 8740 (730–26,230) | 0.161 |
CRP on POD3 (mg/dl) | 11.370 (3.37–29.36) | 12.365 (0.87–42.32) | 0.639 |
f. CR-CL | |||
20 (5.0%) | 384 (95.0%) | ||
DOV on POD1 (ml) | 485 (144–1332) | 250 (15–1490) | < 0.0001 |
DA on POD1 (U/l) | 978 (4–15,944) | 705.5 (0–95,100) | 0.928 |
WBC counts on POD1 (/μl) | 9620 (820–17,090) | 10,400 (635–113,800) | 0.464 |
CRP on POD1 (mg/dl) | 9.595 (3.53–15.37) | 9.495 (0.09–25.84) | 0.945 |
DOV on POD3 (ml) | 459.5 (130–1573) | 229.5 (0–1210) | < 0.0001 |
DA on POD3 (U/l) | 119 (3–2811) | 100 (5–17,200) | 0.787 |
WBC counts on POD3 (/μl) | 8475 (3150–17,030) | 8640 (730–26,230) | 0.526 |
CRP on POD3 (mg/dl) | 7.730 (1.10–21.45) | 12.445 (0.87–42.32) | 0.004 |
g. CR-PPH | |||
28 (6.9%) | 376 (93.1%) | ||
DOV on POD1 (ml) | 187 (60–867) | 275.5 (15–1490) | 0.027 |
DA on POD1 (U/l) | 2313 (63–38,492) | 639 (0–95,100) | < 0.0001 |
WBC counts on POD1 (/μl) | 10,590 (1140–19,190) | 10,380 (635–113,800) | 0.919 |
CRP on POD1 (mg/dl) | 10.705 (6.54–16.02) | 9.465 (0.09–25.84) | 0.189 |
DOV on POD3 (ml) | 195 (30–980) | 240 (0–1573) | 0.165 |
DA on POD3 (U/l) | 217.5 (43–13,230) | 91.5 (3–17,200) | < 0.0001 |
WBC counts on POD3 (/μl) | 11,175 (1460–21,570) | 8560 (730–26,230) | 0.033 |
CRP on POD3 (mg/dl) | 21.090 (4.57–42.32) | 11.370 (0.87–37.57) | < 0.0001 |